Therapeutic targeting of chronic lymphocytic leukemia by silver nanoparticles

Francesco Maria Adamo(University of Perugia), Paolo Sportoletti(University of Perugia)

Research Square

May 10, 2023

10.21203/rs.3.rs-2897424/v1

Cited by 0

Related Papers

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis

|Nature Communications|2017|129

Bcor deficiency perturbs erythro-megakaryopoiesis and cooperates with Dnmt3a loss in acute erythroid leukemia onset in mice

|Leukemia|2020|18

Therapeutic Targeting Potential of Novel Silver Nanoparticles Coated with Anti-CD20 Antibody against Chronic Lymphocytic Leukemia

|Cancers|2023|12

Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI)

|Cancer|2025|10